XML 92 R77.htm IDEA: XBRL DOCUMENT v3.23.1
Long-Term Investments (Details) - Schedule of balance sheet - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Mar. 31, 2023
BioFirst [Member]      
Condensed Balance Sheet Statements, Captions [Line Items]      
Current Assets $ 1,543,151 $ 2,205,669  
Noncurrent Assets 739,472 959,454 $ 801,410
Current Liabilities 2,663,051 2,909,703 1,675,194
Noncurrent Liabilities 103,447 32,522 357,150
Stockholders’ Equity (Deficit) 483,874 222,898  
Rgene [Member]      
Condensed Balance Sheet Statements, Captions [Line Items]      
Current Assets 68,302 73,452  
Noncurrent Assets 303,893 374,423 288,160
Current Liabilities 2,478,868 1,934,786 2,491,974
Noncurrent Liabilities 2,441 $ 2,048
Stockholders’ Equity (Deficit) $ (2,481,309) $ (1,486,911)